New name for merged company

Article

American Pharmaceutical Partners, which produces many multisourceinjectable drugs for cancer, critical care, and infection control,has merged with American BioScience to form Abraxis BioScience, LosAngeles. A major drug in its portfolio is the breast cancer drugAbraxane for Injectable Suspension (paclitaxel protein-boundparticles for injectable suspension) (albumin-bound).

American Pharmaceutical Partners, which produces many multisource injectable drugs for cancer, critical care, and infection control, has merged with American BioScience to form Abraxis BioScience, Los Angeles. A major drug in its portfolio is the breast cancer drug Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound).

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

To go to the Drug Topics homepage, click here http://www.drugtopics.com.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.